With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine.

With deep experience and a passionate commitment to exploration and innovation, Tune is driving through an inflection point in the history of genetic medicine: from targeting a limited range of rare conditions, to addressing thousands of common and complex diseases for which no curative treatment is available.

Biotechnology

Education

Tune Therapeutics

Tune Therapeutics' headquarters in Durham, NC, United States

Charles A. Gersbach

Jason Dean

Kendra Congdon

Tyler Goodwin

Zachary Hale

Georgeta Puscalau

Michael P. Hefferan

Derek Jantz

Christina Jordan

Glenn Murphy

Luis Sanchez-Perez

Erica Li

Kiran Sangaru

Nicole DeNamur

Emi Tokuda

Haley Peper

Stuart Sundseth

Greg Bond

Blythe Sather

John McHutchison

Fyodor Urnov

Dan McHugh

Ali Behbahani

Christina Trojel-Hansen

The Research and Development team at Tune Therapeutics focuses on advancing the TEMPO epigenomic control platform to explore innovative therapeutic strategies for regenerative medicine. Comprising experts from various scientific backgrounds, the team conducts rigorous research, develops novel products, and translates epigenomic insights into effective treatments for complex diseases. Their collaborative efforts aim to unlock new pathways in genetic medicine, addressing a wide range of conditions previously deemed untreatable.

Research and Development

The Technical Operations and Engineering team at Tune Therapeutics is responsible for advancing the TEMPO epigenomic control platform through innovative engineering and operational excellence. They ensure the seamless integration of bioinformatics, laboratory processes, and non-viral delivery systems, while also developing robust software infrastructure and managing laboratory operations. This multidisciplinary team works collaboratively to optimize experimental workflows, scale up production, and support the translation of cutting-edge research into transformative therapies for complex diseases.

Technical Operations and Engineering

The Leadership Team at Tune Therapeutics is responsible for setting the strategic direction and vision of the company, steering its innovative research and development initiatives, and optimizing operational efficiencies. Comprising experienced co-founders and executives, the team drives the advancement of the TEMPO epigenomic control platform, fosters collaboration across departments, and ensures alignment with long-term goals to transform genetic medicine and tackle complex diseases.

Leadership Team

The Quality Assurance and Regulatory Affairs team at Tune Therapeutics is responsible for ensuring that all therapeutic products comply with industry standards and regulatory requirements. They oversee the quality management systems, validate processes, and facilitate compliance with FDA and other regulatory bodies. By prioritizing quality and safety, the team supports the company's mission to advance innovative gene therapies for a wide range of diseases.

Quality Assurance and Regulatory Affairs

Tune Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Technical Operations and Engineering

Leadership Team

Quality Assurance and Regulatory Affairs

Offices

Tune Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Technical Operations and Engineering

Leadership Team

Quality Assurance and Regulatory Affairs

Offices

Related companies